ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Moderna Inc

Moderna Inc (MRNA)

121.14
-0.18
(-0.15%)
Closed July 20 4:00PM
121.21
0.07
(0.06%)
After Hours: 7:24PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
121.21
Bid
115.38
Ask
121.70
Volume
2,206,323
118.80 Day's Range 121.9799
62.55 52 Week Range 170.47
Market Cap
Previous Close
121.32
Open
121.01
Last Trade
17
@
120.84
Last Trade Time
Financial Volume
$ 264,836,047
VWAP
120.035
Average Volume (3m)
4,062,925
Shares Outstanding
383,239,726
Dividend Yield
-
PE Ratio
-9.85
Earnings Per Share (EPS)
-12.3
Revenue
6.85B
Net Profit
-4.71B

About Moderna Inc

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of ... Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
1970
Moderna Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker MRNA. The last closing price for Moderna was $121.32. Over the last year, Moderna shares have traded in a share price range of $ 62.55 to $ 170.47.

Moderna currently has 383,239,726 shares outstanding. The market capitalization of Moderna is $46.49 billion. Moderna has a price to earnings ratio (PE ratio) of -9.85.

Moderna (MRNA) Options Flow Summary

Overall Flow

Bearish

Net Premium

-14M

Calls / Puts

76.19%

Buys / Sells

87.18%

OTM / ITM

94.74%

Sweeps Ratio

0.03%

MRNA Latest News

Apple Joins OpenAI Board, Logitech President Opts Out of Reelection, and More News

Apple (NASDAQ:AAPL) – Apple will obtain an observer role on the OpenAI board as part of an AI agreement, with Phil Schiller chosen for the position. This arrangement will allow Schiller to...

Apple Showcases AI at WWDC 2024, Nvidia Stock Split Starts Today, and More News

Apple (NASDAQ:AAPL) – At today’s Apple Developer Conference (WWDC 2024) kicking off today, the company will demonstrate its prowess in the advanced field of artificial intelligence...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-2.76-2.22634508349123.97129.36421163007504122.6653248CS
4-14.79-10.875136138.07114.023532347122.92488102CS
1215.0314.1552081371106.18170.47105.254062925134.96542264CS
2622.7823.143350604598.43170.4784.063861130117.15687723CS
52-2.28-1.8463033444123.49170.4762.554235835105.53678764CS
156-163.68-57.4537540805284.89497.1762.556569567217.62721632CS
260106.92748.21553533914.29497.1711.548953123148.10691883CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SERVServe Robotics Inc
$ 7.51
(185.55%)
266.26M
AUGXAugmedix Inc
$ 2.27
(147.71%)
24.14M
XCURExicure Inc
$ 0.5351
(76.02%)
14.02M
PSNLPersonalis Inc
$ 3.83
(56.33%)
22.8M
MDBHMDB Capital Holdings LLC
$ 10.675
(37.21%)
126.45k
SPWRSunPower Corporation
$ 0.6735
(-55.40%)
124.61M
HYZNHyzon Motors Inc
$ 0.149
(-47.54%)
23.63M
MEDSTRxADE Health Inc
$ 14.92
(-33.45%)
223.27k
SILOSilo Pharma Inc
$ 2.50
(-27.95%)
11.93M
KITTNauticus Robotics Inc
$ 0.0935
(-27.46%)
28.43M
SERVServe Robotics Inc
$ 7.51
(185.55%)
266.26M
SXTP60 Degrees Pharmaceuticals Inc
$ 0.2602
(5.77%)
226.82M
NVDANVIDIA Corporation
$ 117.93
(-2.61%)
217.11M
SQQQProShares UltraPro Short QQQ
$ 8.46
(2.79%)
188.2M
SPWRSunPower Corporation
$ 0.6735
(-55.40%)
124.61M

MRNA Discussion

View Posts
axelvento axelvento 4 hours ago
Moderna to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024
👍️0
axelvento axelvento 5 hours ago
https://brazilian.report/liveblog/politics-insider/2024/07/18/confirms-first-newcastle-disease-case-in-18-years/
👍️0
axelvento axelvento 5 hours ago
https://edition.cnn.com/2024/07/19/health/bird-flu-colorado/index.html
👍️0
axelvento axelvento 2 days ago
Experimental mRNA Vaccine Hints at Potential Against Glioblastoma

https://www.cancer.gov/news-events/cancer-currents-blog/2024/glioblastoma-mrna-vaccine-layered-nanoparticle
👍️0
axelvento axelvento 3 days ago
$MRNA golden cross on MACD
👍️ 2 😄 1
axelvento axelvento 3 days ago
Bird flu virus infection is usually diagnosed by collecting a swab from the upper respiratory tract (nose or throat) of the sick person.
👍️0
Vexari Vexari 4 days ago
How is bird flu being tested

To determine its existence
💩 1 🤡 1 🤪 1 🦤 1 🪳 1
axelvento axelvento 4 days ago
bird flu- https://fortune.com/2024/07/15/bird-flu-outbreak-colorado-farm-5-workers-test-positive-experts-warn-turning-point-urgent-action-health/
👍️0
axelvento axelvento 5 days ago
https://www.fool.com/investing/2024/07/14/is-moderna-stock-a-buy/
👍️0
axelvento axelvento 6 days ago
Melanoma cancer vaccine results “extremely impressive”
The first vaccine treatment for the form of skin cancer usually caused by sun damage could halve the risk of patients dying or the disease returning, according to early trial results.

Researchers led by a team at New York University combined a vaccine using the same mRNA technology as many COVID jabs with an established immunotherapy called pembrolizumab. It was given to patients after they had surgery to remove stage 3 or stage 4 melanoma.

After three years, 75% of those who had the vaccine and pembrolizumab were still cancer-free, compared to 56% of people who only received pembrolizumab.

Iain Foulkes, our executive director of research and innovation explained that the results “show positive signs of the mRNA vaccine’s long-lasting effectiveness”, although larger and longer trials are still needed.

Unlike traditional vaccines, which are used to prevent disease, cancer vaccines are used to treat cancers. The vaccine used in this trial, mRNA-4157 (created by Moderna), is different for every patient. Scientists personalise it to help people’s immune system identify their specific cancer cells. Pembrolizumab, a type of immunotherapy called a checkpoint inhibitor, supports this by effectively taking the brakes off of immune cells called T cells.

Speaking to journalists at ASCO, Swanton called the results “extremely impressive”.

“The new vaccine approach is another piece of the puzzle that will allow more patients to be cured, hopefully, or fewer patients to suffer disease relapse. Ultimately it will contribute to survival rates improving continually over the next decades and more.”
👍️ 2 😃 1
axelvento axelvento 6 days ago
https://www.sciencealert.com/new-bird-flu-discovery-suggests-cows-are-a-threat-for-future-pandemics
👍️ 2 😀 1
axelvento axelvento 1 week ago
https://www.nature.com/articles/d41586-024-02237-4
👍️0
axelvento axelvento 1 week ago
https://www.reuters.com/business/healthcare-pharmaceuticals/bird-flu-strains-spread-around-globe-2024-07-10/
👍️0
axelvento axelvento 1 week ago
Santa Claus is there NO VAX
👍️0
Vexari Vexari 1 week ago
Through fear

And dominance

Without knowing

Its ramifications
👎️ 1 🗑️ 1 🤪 1 🦤 1 🪳 1
Vexari Vexari 1 week ago
If so

In what form

Shades of

Jussie Smollett
💩 1 🗑️ 1 🤡 1 🦤 1 🪳 1
Vexari Vexari 1 week ago
Do viruses exist
👎️ 1 💩 1 🤡 1 🤪 1 🦤 1
hotdawg hotdawg 1 week ago
If he works for the government, why is he asking for donations?
👍️0
axelvento axelvento 1 week ago
Bridge RNA: A new gene editing technique that could overcome the limitations of CRISPR

https://www.labiotech.eu/in-depth/bridge-rna-gene-editing/
👍️0
axelvento axelvento 1 week ago
‘It’s Going to Be Catastrophic’: Why the Next Pandemic Will Be Worse Than COVID

https://www.dailysignal.com/2024/07/08/chinas-covid-deception-cost-us-18-trillion-1-1-million-lives/

$NOVAX
👍️0
axelvento axelvento 1 week ago
https://www.nature.com/articles/d41586-024-02170-6
👍️0
axelvento axelvento 2 weeks ago
long live the pussy NO VAX
👍️ 2 😀 1 😃 1
Vexari Vexari 2 weeks ago
It's the way it's been done

Since the old days

The Reach
💤 1 💩 1 🤡 1 🦃 1 🦤 1
Vexari Vexari 2 weeks ago
Feel the pain
💩 1 🤡 1 🤢 1 🤮 1 🦤 1
axelvento axelvento 2 weeks ago
heal your brain.... useless NO VAX
👋 1 👍️ 2
Vexari Vexari 2 weeks ago
Be afraid

But we can help

No worries
💩 1 🤡 1 🤪 1 🦤 1 🪳 1
axelvento axelvento 2 weeks ago
Bird flu spread to cows takes 'dangerous' step towards infecting humans through respiration, scientists warn

https://news.sky.com/story/bird-flu-spread-to-cows-takes-dangerous-step-towards-infecting-humans-through-respiration-scientists-warn-13175177
👍️ 2
Vexari Vexari 2 weeks ago
Japan to ban MRNA

As turbo cancers among vaxxed

Skyrocketing

Turbo cancers are exploding among the vaccinated according to Japan’s leading oncologist who has slammed the mainstream media and Big Pharma in the West for covering up the extent of the medical crisis engulfing the world.

Prof. Emeritus Dr. Masanori Fukushima was ordered by the Japanese government to investigate why excess deaths skyrocketed in Japan in recent years.

His findings were conclusive: mRNA has destroyed immune systems and opened a Pandora’s box of autoimmune diseases, neurodegenerative diseases, cancer, and infections.

The Professor has a dire warning for those in the West – do not listen to mainstream media and Big Pharma as they are not engaged in science, but rather a eugenics experiment, and they have proven themselves to be enemies of the people.
💩 1 🗑️ 1 🤡 1 🤪 1 🦤 1
DewDiligence DewDiligence 2 weeks ago
Mitsubishi Tanabe Pharma will co-promote MRNA’s vaccines_in Japan:

https://www.accesswire.com/viewarticle.aspx?id=886055&lang=en

Financial terms of the co-promotion have not been disclosed.
👍️ 1
Vexari Vexari 2 weeks ago
Don't see the free advertising like before

Will this affect the bottom line

What could happen

Moving forward
👎️ 1 💤 1 🗑️ 1 🤡 1 🦤 1
axelvento axelvento 2 weeks ago
https://www.economist.com/the-economist-explains/2024/07/05/why-finland-and-others-are-vaccinating-people-against-bird-flu

$MRNA
👍️ 2
Vexari Vexari 2 weeks ago
Would depend on what's being hacked

Has nothing to do with health
👎️ 1 💩 1 🤡 1 🤪 1 🪳 1
Vexari Vexari 2 weeks ago
What about clinicals

If this is major test

Sounds fishy
💩 1 🗑️ 1 🤡 1 🤪 1 🦤 1
axelvento axelvento 2 weeks ago
In a 153-page written ruling on Tuesday, Mr Justice Meade concluded one of the European Moderna patents, labelled EP565, was “invalid”.

But the judge said a different patent, called EP949, was “valid” and was infringed by Pfizer and BioNTech.

A Moderna statement said: “We are pleased that the UK High Court recognised the innovation of Moderna scientists by confirming the validity and infringement of the EP949 patent and that (the) defendants were not entitled to use Moderna’s patented technology for any infringing activity after March 7 2022.

https://www.standard.co.uk/news/crime/pfizer-moderna-high-court-netherlands-germany-b1168104.html
👍️ 3
DewDiligence DewDiligence 2 weeks ago
The article is behind a paywall—can you paraphrase the key points? TIA
👍️0
axelvento axelvento 2 weeks ago
Looking for the Best Health Hacks- Try Vaccines "anti-vax"

https://www.scientificamerican.com/article/vaccines-are-the-safest-health-hack/
👍️ 2
axelvento axelvento 2 weeks ago
Moderna secures partial victory in Covid vaccine legal fight

https://www.ft.com/content/c57bc08f-50b3-42ef-ad44-4d592b189ce7
👍️0
axelvento axelvento 2 weeks ago
Scientists wary of bird flu pandemic 'unfolding in slow motion'

"It almost seems like a pandemic unfolding in slow motion," said Scott Hensley, a professor of microbiology at the University of Pennsylvania. "Right now, the threat is pretty low ... but that could change in a heartbeat."

https://www.reuters.com/business/healthcare-pharmaceuticals/scientists-wary-bird-flu-pandemic-unfolding-slow-motion-2024-07-01/
👍️ 2
axelvento axelvento 2 weeks ago
10 clinical trials to watch in the second half of 2024
COMPANY: Moderna
DISEASE: Cytomegalovirus
TREATMENT TYPE: mRNA Vaccine

There are no vaccines for cytomegalovirus, or CMV.
Success would also open up the potential of a product analysts think could eventually generate more than $3 billion in peak yearly sales.

https://www.biopharmadive.com/news/biotech-10-clinical-trials-watch-2024-second-half/720005/
👍️0
axelvento axelvento 2 weeks ago
bouncer...
👍️0
$Green$ $Green$ 3 weeks ago
Making another buy call at this level

8+ billion cash
👍️0
axelvento axelvento 3 weeks ago
today announced a project award of $176 million through the Rapid Response Partnership Vehicle (RRPV) to accelerate the development of mRNA-based pandemic influenza vaccines. The RRPV is a Consortium funded by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS).

https://investors.modernatx.com/news/news-details/2024/Moderna-Receives-Project-Award-through-BARDAs-Rapid-Response-Partnership-Vehicle-Consortium-to-Accelerate-Development-of-mRNA-based-Pandemic-Influenza-Vaccine/default.aspx
👍️ 2
axelvento axelvento 3 weeks ago
Combined COVID-flu vaccines are coming: Moderna jab clears major test

https://www.nature.com/articles/d41586-024-02121-1
👍️0
axelvento axelvento 3 weeks ago
EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Marketing Authorization Of Moderna’s RSV Vaccine, mRESVIA(R)

https://investors.modernatx.com/news/news-details/2024/EMA-Committee-For-Medicinal-Products-For-Human-Use-Adopts-Positive-Opinion-Recommending-Marketing-Authorization-Of-Modernas-RSV-Vaccine-mRESVIAR/default.aspx
👍️0
axelvento axelvento 3 weeks ago
Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular Carcinoma Under Collaboration with Moderna

Lin Guey, PhD, Chief Scientific Officer of Therapeutics Research Ventures and Biotherapeutics at Moderna, stated, "We are thrilled with the significant progress we've made in advancing in vivo CAR-M therapies alongside Carisma. We eagerly anticipate further development of the nominated candidate for patients with solid tumors, and we look forward to continued success as we develop additional in vivo CAR-M together to bring new therapies to patients with HCC and other cancers."

The in vivo CAR-M program targeting GPC3 is being developed under the 2022 strategic collaboration agreement between Carisma and Moderna to discover, develop, and commercialize in vivo engineered CAR-M therapeutics for the treatment of cancer. In addition to this program, Moderna has nominated four undisclosed oncology research targets under the collaboration. Carisma is responsible for the discovery and optimization of development candidates, while Moderna will lead the development and commercialization of resulting therapeutics.

https://ir.carismatx.com/news-releases/news-release-details/carisma-therapeutics-announces-nomination-first-vivo-car-m
👍️ 2
axelvento axelvento 3 weeks ago
RNA Vaccines For Cancer $$$$$$$$$$$$

https://www.science.org/content/blog-post/rna-vaccines-cancer
👍️ 2
Vexari Vexari 3 weeks ago
What is bird flu

And how did it cross over

To cows

Get it yet

It's all a mind game
💩 1 🗑️ 1 🤡 1 🤪 1 🦤 1
DewDiligence DewDiligence 3 weeks ago
Nice digs! (eom)
👍️0
axelvento axelvento 3 weeks ago
Moderna offers a sneak peek inside of its new Kendall Square headquarters

https://www.bostonglobe.com/2024/06/26/business/moderna-headquarters/
👍️0
axelvento axelvento 3 weeks ago
https://www.forbes.com/sites/ariannajohnson/2024/06/26/bird-flu-h5n1-explained-finland-will-start-vaccinating-humans-in-a-global-first/
💤 1

Your Recent History

Delayed Upgrade Clock